Skip to main content
. 2018 Jan 7;7(2):317–324. doi: 10.1002/cam4.1286

Figure 1.

Figure 1

The distribution of the steady‐state trough plasma concentrations of Imatinib (A) and NDI (B) at 400 mg daily (n = 122). The vertical dashed lines indicate quartiles. (NDI: N‐desmethyl Imatinib)